SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ID Biomedical - Elephant Hunting?? (IDBEF)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (3)1/24/1999 3:21:00 PM
From: Kaiser Soza  Read Replies (2) of 27
 
Hi Steve, Thanks for your comments. I have spoken to all the management at ID since the day they went public, and I must say I was thrilled with the management changes. The recent convert was perhaps a reflection of the market we are in and timing issues with the company. They are very confident of the near future I believe, but like almost every biotech right now, the burn rate is a concern. This could change very quickly. The market is ignoring the Pasteur Merieux deal and looking for deal#2 with another big Pharma on the CPT related tests. The good news is that with QLT, Biomira and a number of others, the market will buck up "very" fast if the right set of circumstances unfold. I think these guys are due and seem close on a number of fronts. Regards, Kaiser....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News